PreprintAll rights reservedbioRxiv
Targeting the CDK4-Cyclin D Complex: A New Generation of Selective Kinase Inhibitors for Cancer Therapy
- 1Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunidad Valenciana (FISABIO)
Related
- Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study
- Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer
- Targeting tumor-selective membrane-associated PCNA enables selective antibody-drug conjugate therapy.
- Synthesis, Hypoxia-Selective Anti-Oral Cancer Activity and Mechanism of a CA IX-Targeting Platinum(II) Complex Based on Pyridoxal 4-Sulfamoylphenylhydrazone
- Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction
BibTeX
@misc{fuentesbaile2026targeting,
title = {{Targeting the CDK4-Cyclin D Complex: A New Generation of Selective Kinase Inhibitors for Cancer Therapy}},
author = {M. Fuentes-Baile and J. A. Encinar and S. Araujo-Abad and E. Perez-Valenciano and P. Garcia-Morales and L. Fuertes-Garcia and C. de Juan Romero and M. Saceda},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.18.752547},
url = {https://www.biorxiv.org/content/10.64898/2026.09.18.752547v1},
}
RIS
TY - UNPB
TI - Targeting the CDK4-Cyclin D Complex: A New Generation of Selective Kinase Inhibitors for Cancer Therapy
AU - M. Fuentes-Baile
AU - J. A. Encinar
AU - S. Araujo-Abad
AU - E. Perez-Valenciano
AU - P. Garcia-Morales
AU - L. Fuertes-Garcia
AU - C. de Juan Romero
AU - M. Saceda
PY - 2026
DA - 2026/09/18
PB - bioRxiv
DO - 10.64898/2026.09.18.752547
UR - https://www.biorxiv.org/content/10.64898/2026.09.18.752547v1
ER -